Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ideaya Biosciences Inc (IDYA)

  • Business News
  • Sept. 03, 2025, 10:04 UTC
  • 0
  • 0 comments

IDEAYA Biosciences Announces IND Submission for IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deletion Solid Tumors

Market reaction Comment Full text

Enanta Pharmaceuticals Inc (ENTA)

  • Business News
  • Sept. 03, 2025, 10:01 UTC
  • 0
  • 0 comments

Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.

Market reaction Comment Full text

Aclarion Inc (ACON)

  • Business News
  • Sept. 03, 2025, 10:00 UTC
  • 0
  • 0 comments

Aclarion Appoints Greg Gould as Chief Financial Officer

Market reaction Comment Full text

Hyphens Pharma International Limited (1J5)

  • Business News
  • Sept. 03, 2025, 09:33 UTC
  • 0
  • 0 comments

Hyphens Notification - Evolve Capitals Equity Research - 1H25: Near Term Performance Likely to Remain Subdued Before Modest Recovery

Market reaction Comment Full text

Hyphens Pharma International Limited (1J5)

  • Business News
  • Sept. 03, 2025, 09:28 UTC
  • 0
  • 0 comments

Evolve Capital’s Equity Research – Near Term Performance Likely to Remain Subdued Before Modest Recovery

Market reaction Comment Full text

Altimmune Inc (ALT)

  • Business News
  • Sept. 03, 2025, 09:15 UTC
  • 0
  • 0 comments

ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

Valneva SE (INRLF)

  • Business News
  • Sept. 03, 2025, 08:47 UTC
  • 0
  • 0 comments

Harnessing Human Potential to Power Vaccine Innovation

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 03, 2025, 08:04 UTC
  • 0
  • 0 comments

Gamescom 2025 Recap: Biggest Announcements and Highlights

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Sept. 03, 2025, 07:55 UTC
  • 0
  • 0 comments

AI in Game Design: Smarter NPCs, Dynamic Storytelling, and Procedural Worlds

Market reaction Comment Full text

Nutex Health Inc (NUTX)

  • Business News
  • Sept. 03, 2025, 07:49 UTC
  • 0
  • 0 comments

NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(9936)
  • Event(412)
  • SEC News(168157)
  • FDA Approval(9362)
  • Company Report(721)
  • Business News(111948)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin